Private limited company · Asker
SERO AS
ActiveManufacture of pharmaceutical preparations (21.200)
The life line 1997–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 211.3m.
- Chair took office§ 07
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
SERO AS is a private limited company in Asker, founded in 1963, in the industry manufacture of pharmaceutical preparations. The chief executive is Jens Stefan Nicolai Kernstock, and the chair of the board is Knut Weydahl Eldjarn. In 2025 the company had NOK 211.3m in operating revenue and a net profit of NOK 42.4m.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 13 Nov 2026
- Number of employees 76 → 77
- Number of employees 75 → 76
- Number of employees 73 → 75
- Annual accounts filed 2024 → 2025
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
1 point
- OKEquity ratio 74.7%, above the industry median
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 211.3m in 2025
Revenue
NOK 211.3m
+13.5% from 2024
20232025
Operating profit
NOK 53.9m
+27.6% from 2024
20232025
Net profit
NOK 42.4m
+24.7% from 2024
20232025
Equity
NOK 178.7m
+14.4% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 34%
- Depreciation 1%
- Other operating costs 12%
- Not specified in the source 27%
- Left as operating result 26%
Of the net profit for 2025, NOK 22.4m stayed in the company. The rest, NOK 20.0m, is an assumed dividend.
The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 74.7%
- SERO AS, 2025
- Industry median, assumed: NOK 31.9m · 7.0% · 50.3% · +3.9%
Equity NOK 178.7m75% of the assets (NOK 239.1m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 28 companies in 21.200 Manufacture of pharmaceutical preparations, not stated by the source.
Finances
§ 06 Accounts
28 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 211,254 | 186,075 | 167,321 | |
| Operating profit | 53,870 | 42,205 | 39,664 | |
| Profit before tax | 54,407 | 43,555 | 39,026 | |
| Net profit | 42,442 | 34,022 | 30,505 | |
| Total assets | 239,147 | 213,452 | 179,153 | |
| Equity | 178,670 | 156,228 | 134,206 | |
| Liabilities | 60,478 | 57,225 | 44,947 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 28 years →
Management and ownership
§ 07 Officers
12 officers now
- BDO ASAuditor
- Jens Stefan Nicolai KernstockChief executive
- Knut Weydahl EldjarnChair of the board since 2023
- Ole Henrik EideBoard member since 2023
- Eileen EldjarnBoard member since 2023
- Camilla Eldjarn HuitfeldtBoard member since 2024
Source: the Brønnøysund Register Centre, read 22 Oct 2026 · All 12 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
Styrets leder og ett styremedlem i fellesskap.
May sign for the company:
Styrets leder og ett styremedlem i fellesskap.
Power of procuration:
Daglig leder alene. Styrets leder alene.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 17 Nov 2026
Management and ownership
§ 09 Owners
None registered
No owners registered.The Tax Administration's shareholder register covers limited companies and has no owners for this business. Checked 15 Nov 2026.
Management and ownership
§ 10 Group
None registered
Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
15 connections
- Person
- Company
8 people link SERO AS to 11 other companies: Knut Erik Weydahl Eldjarn 4, Ole Henrik Eide 3, Jens Stefan Nicolai Kernstock 2, Vilde Årdal 2, Astrid Torunn Eldjarn 1 and Camilla Eldjarn Huitfeldt 1, …
Source: the Brønnøysund Register Centre, read 22 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
16 since 2015
Events per year
20152026
Since 2015: 12 announcements, 7 register changes and 2 tenders won. Most happened in 2023 and 2026.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 15 Nov 2026. Register changes are Intelligo's own observations. · All 16 events →
Events and registers
§ 14 Notices
12, latest 16 Jul 2026
- Godkjente årsregnskap
- Styre
- Styre
Source: The Brønnøysund Register Centre's announcements ↗, read 15 Nov 2026 · All 12 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 12 Mar 1995
- VATRegistered
- The Register of Business EnterprisesRegistered 29 Mar 1989
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Produksjon, distribusjon og salg av kontrollsera, reagenser og instrumenter til bruk i analysevirksomhet i medisinske og andre laboratorier.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
4 tenders
- 2023
- 2025
- 2026
- 2026
- Won
- Lost
| Awarded | Contract | Buyer | Outcome |
|---|---|---|---|
| Apr 2026 | Kontroller för kemi/immunkemi | Västra Götalandsregionen | Lost |
| Apr 2026 | 77491 RA KLM Avd. for medisinsk biokjemi Analyseinstrument | Oslo Universitetssykehus HF (hovedenhet) | Won |
| — | Kontroller till analysarbete | Region Gävleborg | Lost |
Source: Doffin and TED, read 5 Nov 2026. · All 4 tenders →
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 21.200
Value awarded in Doffin and TED since 2023, among the companies SERO AS has met in tenders:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
6 questions
- Who is the chief executive of SERO AS?
Jens Stefan Nicolai Kernstock. § 07 - What was the revenue in 2025?
NOK 211.3m in the company. § 06 - Who can sign for SERO AS?
Styrets leder og ett styremedlem i fellesskap. § 08 - Who is the auditor?
BDO AS. § 07 - Where is SERO AS based?
Stasjonsveien 44, 1396 Billingstad. - When was SERO AS founded?
17 Jun 1963, registered in the Register of Business Enterprises 29 Mar 1989. § 16
The answers come from the sections linked to, with their sources.